Others

Items 751-800 of 12610

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. G6PD activator

    G6PD activator AG1 is a glucose-6-phosphate dehydrogenase (G6PD) activator with an EC50 of 3 ?μ, extracted from patent WO2019023264A1, compound AG1.
  2. Leukemogenesis promoter

    TFMB-(R)-2-HG, a cell membrane-permeable version of (R)-2-HG, is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cells differentiation in response to estrogen withdrawal.
  3. DNA2 inhibitor

    DNA2 inhibitor C5 is a potent, competitive and specific inhibitor of DNA2 nuclease activity with an IC50 of 20 μM.
  4. Vanin-1 enzyme inhibitor

    Vanin-1-IN-1 is an inhibitor of vanin-1 enzyme which is a cell surface associated, giycosyiphosphatidyS inositol (GPi) anchored protein and plays an important role in metabolism and inflammation.
  5. Monooctyl succinate is a monoester, which can be used as a surfactants and a potential fragrance releaser.
  6. KX-01-191 (compound 5c??) is a tin-precursor.
  7. N-Dodecyl-β-D-maltoside (Lauryl Maltoside) is a derivatives of pyrene (Py), and it is a alkyl maltopyranoside detergent, especially in transporters and respiratory complexes.
  8. SJA710-6 is a small molecule able to selectively differentiate MSCs toward hepatocyte-like cells.
  9. 2'-Fluorothymidine (2'-Fluoro-2'-deoxythymidine), a bioisostere of both thymidine (TdR) and methyluridine, is a putative highly selective substrate for thymidine kinase type 2 (TK2).
  10. KMO inhibitor

    GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively.
  11. RUVBL1/2 complex inhibitor

    CB-6644 is a selective inhibitor of RUVBL1/2 complex with anti-cancer activity. CB-6644 blocks the ATPase activity of RUVBL1/2 with an IC50 of 15 nM.
  12. fucosylation inhibitor

    SGN-2FF is an oral inhibitor of fucosylation, directly inhibits fucosyltransferase activity, and possesses antitumor activity.
  13. RPH-2823 is a basic triamterene derivative, with diuretic activity.
  14. chymase inhibitor

    Fulacimstat is an orally available chymase inhibitor, with IC50s of 4, 3 nM for human and hamster chymase enzyme, respectively.
  15. Epsilon-momfluorothrin is a type I synthetic pyrethroid insecticide, activates constitutive androstane receptor (CAR), and induces hepatocellular tumors in rats.
  16. SHMT1/2 inhibitor

    SHIN1 (RZ-2994) is a human serine hydroxymethyltransferse 1 and 2 (SHMT1/2) inhibitor with IC50s of 5 and 13 nM, respectively, in an in vitro assay.
  17. 6-Aminochrysene (6-Aminochrysene) is an aromatic amine used as a chemotherapeutic agent in the treatment of splenomegaly, myeloid leukemia, and breast cancer.
  18. 17β-HSD3 inhibitor

    TC HSD 21 is a potent 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) inhibitor with an IC50 of 14 nM. TC HSD 21 shows excellent selectivity over 17β-HSD isoenzymes and nuclear receptors.
  19. immunostimulant

    Sotirimod is an immunostimulant, and can potentially treat for actinic keratosis.
  20. cerebral vasodilator agent

    Viquidil (LM 192) is a cerebral vasodilator agent .
  21. paramagnetic contrast agent

    Gadopentetic acid (Gd-DTPA) is an paramagnetic contrast agent commonly implemented by a bolus intravenous injection (i.v.) in Dynamic contrast-enhanced MRI (DCE-MRI) studies. The initial concentration of Gadopentetic acid (Gd-DTPA) in the plasma ([Gd-DTPA0]) is an important parameter for DCE-MRI.
  22. NCX1022 is an NO-releasing derivative of Hydrocortisone, which is the most widely used anti-inflammatory drug for the treatment of skin inflammation.
  23. apo inhibitor

    PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells that could rescue impairments of mitochondrial motility and neurite outgrowth.
  24. anti-inflammatory

    Bucloxic acid is an anti-inflammatory pyrrazole derivative. Bucloxic acid can be used in the treatment of chronic glomerular nephropathies.
  25. Paliroden is an orally bioactive neurotrophic, non-peptidic compound that activates synthesis of endogenous neurotrophines, used for treatment of Alzheimer's Disease and Parkinson's.
  26. SAHA chloroalkane T1 is a chloroalkane capture tag by tethering Vorinostat (SAHA) and a chloroalkane tag T1.
  27. platelet aggregation inhibitor

    Ifenprodil glucuronide is a derivative of Ifenprodil. Ifenprodil is a vasodilator and an inhibitor of platelet aggregation, and Ifenprodil glucuronide has no effect on platelet aggregation and arterial contraction.
  28. protein-based AB5-type exotoxin

    Pertussis Toxin is a protein-based AB5-type exotoxin produced by the bacterium Bordetella pertussis, which causes whooping cough.
  29. GAGs biosynthesis

    Pro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
  30. KLC2-SKIP Interaction inhibitor

    Kinesore is an inhibitor of the KLC2-SKIP Interaction.
  31. oral antidiabetic agent

    BM-131246 is an oral antidiabetic agent.
  32. Bencianol is a the semisynthetic flavinoid, with anti-spasmogenic activities.
  33. ST inhibitor

    Lith-O-Asp is a sialytransferase (ST) inhibitor, with IC50s of 12-37 μM.
  34. BRAG2 inhibitor

    Bragsin2 is a potent, selective and noncompetitive nucleotide exchange factor BRAG2 inhibitor, with an IC50 of 3 μM.
  35. ArfGEF BRAG2 inhibitor

    Bragsin1 is a potent, selective and noncompetitive inhibitor of the ArfGEF BRAG2, inhibits Arf GTPase activation, with an IC50 of 3 μM.
  36. Oxyfenamate has anti-anxiety actions for use in anxiety neuroses.
  37. spastin inhibitor

    Spastazoline is a potent and selective spastin (a microtubule-severing AAA protein) inhibitor, with an IC50 of 99 nM for Human spastin. Spastazoline shows no effect on ATPase activity of a recombinant human VPS4.
  38. MTHFD1/MTHFD2 inhibitor

    LY 345899 is a methylene tetrahydrofolate dehydrogenase (MTHFD1; DC301) and MTHFD2 inhibitor with IC50 values of 96 nM and 663 nM, respectively and a Ki of 0.018 μM.
  39. Padsevonil is a potent antiepileptic agent.
  40. Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.
  41. IAA antagonist

    PEO-IAA is an indole-3-acetic acid (IAA) antagonist. PEO-IAA is an auxin antagonist that binds to transport inhibitor response 1/auxin signaling F-box proteins (TIR1/AFBs).
  42. hepcidin production inhibitor

    DS28120313 (compound 32) is an orally hepcidin production inhibitor with an IC50 of 0.093 μM.
  43. Tegadifur is a fluorine-containing and anti-metabolic drug.
  44. rat adenylate kinase II inhibitor

    N6-Methyladenosine 5'-monophosphate disodium salt is an activator of glycogen phosphorylase b, with a Ka value of 22 ?M. N6-Methyladenosine 5'-monophosphate disodium salt is a non-competitive rat adenylate kinase II inhibitor.
  45. aminocryptand ligand

    Octaaminocryptand 1 is an aminocryptand ligand.
  46. neurotoxin inhibitor

    Neurotoxin Inhibitor is a neurotoxin inhibitor.
  47. FOXM1 inhibitor

    FDI-6 is an inhibitor of FOXM1. FDI-6 binds directly to FOXM1 protein, to displace FOXM1 from genomic targets in MCF-7 breast cancer cells, and induce concomitant transcriptional down-regulation.
  48. Guancydine (Guancidine) is an antihypertensive agent.
  49. DSP-4 hydrochloride (Neurotoxin DSP 4 hydrochloride) is a highly selective neurotoxin and readily passes the blood-brain barrier with neurotoxic effects on noradrenergic neurons of adult and developing rats, can be used for the temporary selective degradation of the central and peripheral noradrenergic neurons, mainly those from the locus coeruleus (LC).
  50. protease inhibitor

    N-alpha-Tosyl-L-lysine chloromethyl ketone (TLCK), a trypsin like protease inhibitor, sensitizes HeLa cells to Fas-mediated cell death.

Items 751-800 of 12610

Page
per page
Set Descending Direction